A variation of a 2-in-1 adaptive design to seamlessly expand a selected dose from a phase 2 trial to a phase 3 trial for oncology drug development
| Autor: | Zhang, Pingye, Li, Xiaoyun (Nicole), Lu, Kaifeng, Wu, Chengqing, Ge, Miaomiao |
|---|---|
| Zdroj: | In Contemporary Clinical Trials April 2023 127 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect